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1. Introduction
  Diabetes mellitus is a chromic metabolic disorder associated 
with long term damages, dysfunctions, failure of organs 
especially the eyes, kidneys, nerves and cardiovascular system[1]. 
Glycoproteins are carbohydrate linked protein macromolecules 
found in the cell surface, which form the principal component 
of animal cells. Hexose, hexosamine, and sialic acid are the 
basic components of the glycoproteins. They play an important 
role in membrane transport, cell differentiation and recognition, 
the adhesion of macromolecules to the cell surface, and the 
secretion and absorption of macromolecules[2]. Under diabetic 
conditions, reactive oxygen species are produced mainly 
through glycation reaction, which occurs in various tissues 
and may play an important role in the development of diabetic 
complications. Advanced glycation end products (AGEs) 
modify galactose, fucose and sialic acid contents of specific 
cellular glycoproteins[3]. Impaired metabolism of glycoproteins 
plays a major role in the pathogenesis of diabetes mellitus[4,5]. 
In the present study, the pharmacological effect of ethanolic 
extract of Evolvulus alsinoides (E. alsinoides) on glycoprotein 
metabolism was investigated and the results were compared with 
glibenclamide standard drug.
2. Materials and methods
2.1. Plant material
   The whole plant of E. alsinoides L. used for the investigation 
was obtained from Coimbatore District, Tamilnadu, India. The 
plant was authenticated by Dr. P. Satyanarayana, Botanical 
Survey of India, TNAU Campus, Coimbatore (The voucher 
number is BSI/SRC/5/23/2011-12/Tech.-514). Fresh plant 
material was washed under running tap water, air dried and 
powdered. 
2.2. Sample extraction
   100 g of dried plant powder was extracted in 500 mL of 
ethanol in an orbitory shaker for 72 h. Repeated extraction 
was done with the same solvent till clear colorless solvent is 
obtained. Obtained extract was evaporated and stored at 0-4 曟 
in an air tight container.
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2.3. Animals
   Wistar albino rats weighing about 150-180 g were procured 
from Karpagam University Animal House, Coimbatore, India. 
The animals were under standard conditions and fed with rodent 
diet and water. The study was approved by Institutional Animal 
Ethical Committee constituted for the purpose of CPCSEA.
2.4. Induction of experimental diabetes
   Rats were rendered diabetic by a single intraperitoneal 
injection of freshly prepared streptozotocin (45 mg/kg bw) in 0.1 
M citrate buffer (pH 4.5) in a volume of 1 mL/kg body weight[6]. 
Diabetes was identified in rats by moderate polydypsia and 
marked polyuria. After 48 h of streptozotocin administration, 
blood glucose levels were estimated and rats with a blood glucose 
ranging between 200-400 mg/dL were considered diabetic and 
used for the experiments.
2.5. Experimental design
   The animals were divided into five groups of six animals each. 
Group I served as a control; group II consisted of streptozotocin-
induced diabetic rats; group III consisted of streptozotocin-
induced diabetic rats treated with glibenclamide (1.25 mg/kg bw/
d/rat); groups IV consisted of streptozotocin-induced diabetic 
rats treated ethanolic extract of E. alsinoides (150 mg/kg bw/d/
rat) and group V were normal rats treated with ethanolic extract 
of E. alsinoides (150 mg/kg bw/d/rat) 
2.6. Biochemical studies
   After 45 d of treatment the animals were sacrificed under 
chloroform anesthesia. The tissues (liver and kidney) were 
quickly excised off, a portion of tissues washed with saline. 
Delipidised residues of tissues were prepared according to the 
method of Folch et al[7]. A known amount of delipidised residues 
of the tissues were hydrolysed with 2.0 mL of 4 N HCl at 100 曟 
for 4 h. The hydrolyzed material was neutralized and used for the 
estimation of hexose[8], hexosamine[9] and sialic acid[10].
2.7. Statistical analysis
   The values were expressed as Mean依SD (n=6). The statistical 
analysis was carried out by one way analysis of variance using 
SPSS (version 10) statistical analysis program. Statistical 
significance was considered at P<0.05.
3. Results
   Hyperglycaemia in experimental diabetic rats leads to a 
decreased utilization of glucose by insulin dependent pathways, 
thereby enhancing the formation of glycoproteins[11]. At the 
cell surface or inside the cells, the glycocomponents such as 
fucose and sialic acid form specific structures, called glycanic 
chains covalently linked to lipids or proteins. An increase in the 
biosynthesis and or a decrease in the metabolism of glycoproteins 
could be related to the deposition of these materials in the basal 
membrane of pancreatic cells. In recent times, many traditionally 
important medicinal plants have been tested for their efficacy 
against impaired glycoprotein levels in diabetes[12]. The present 
study was undertaken to find out the therapeutic effect of E. 
alsinoides on glycoprotein metabolism in streptozotocin induced 
diabetic rats
Table 1
Effect of ethanolic extract of E. alsinoides on the hexose and 
hexosamine in the liver of control and experimental rats.
Groups
Glycoproteins (mg/g of tissue)
Hexose Hexosamine
Control 22.10依0.79a 6.64依0.15a
Diabetic control 53.57依2.75d 9.37依0.71b
Diabetic +  Glibenclamide 27.37依0.72b 6.97依0.20a
Diabetic +  E. alsinoides 30.51依1.54c 7.03依0.27a
E. alsinoides alone 22.36依0.76a 6.71依0.16a
Values are expressed as Mean依SD for six animals. Values not sharing 
common superscript letters (a-f) differ significantly at P<0.05 (DMRT).
Table 2 
Effect of ethanolic extract of E. alsinoides on the hexose and 
hexosamine in the kidney of control and experimental rats.
Groups
Glycoproteins (mg/g of defatted tissue)
Hexose Hexosamine
Control 21.39依0.93a 6.01依0.20a
Diabetic control 56.45依3.46c 7.75依1.07b
Diabetic +  Glibenclamide  23.98依1.17ab 6.36依0.57a
Diabetic +  E. alsinoides 26.30依2.19b 6.41依0.53a
E. alsinoides alone 21.79依0.94a 6.07依0.30a
Values are expressed as Mean依SD for six animals. Values not sharing 
common superscript letters (a-f) differ significantly at P<0.05 (DMRT).
   Glycoprotein levels in the tissues were determined by the 
balance between their biosynthetic rate and their degradation 
of glycohydrolases. Abnormalities in the glycoprotein content 
may plan an important role in the pathophysiology of diabetes 
mellitus. Several hypotheses have been proposed to explain 
tissue glycoprotein abnormalities, functions and its secondary 
complications in diabetes[2]. 
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Figure 1. Effect of ethanolic extract of E. alsinoides on sialic acid in 
the liver and kidney of control and experimental rats.
Values are expressed as Mean依SD for six animals. Values not 
sharing common superscript letters (a-f) differ significantly at P< 
0.05 (DMRT).
Diabetic control
Diabetic+Glibenclamide
Diabetic+E. alsinoides
E. alsinoides alone
   In this study, the levels of glycoproteins like hexose, 
hexosamine and sialic acid in the liver and kidney of normal 
and diabetic rats were studied and the results were depicted 
in Table 1, 2 and Figure 1. The high levels of all glycoproteins 
were observed in the tissues of the streptozotocin induced rats 
when compared with the normal control rats. Treatment with 
ethanolic extract of E. alsinoides  for 45 d resulted in a significant 
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reduction of glycoproteins in the tissues of diabetic rats and there 
was no significant difference were observed between control and 
E. alsinoides alone group rats. 
   Increased glycosylation of various proteins in diabetic patients 
has been reported[13]. In this study, we have observed increased 
levels of hexose, hexosamine and sialic acid in the liver and 
kidney of streptozotocin induced diabetic rats. The increase 
in plasma glycoprotein components has been associated with 
the severity and duration of diabetes. In hyperglycaemia, free 
amino groups of proteins react slowly with the carbonyl groups 
of reducing sugars such as glucose, to yield a Schiff’s-base 
intermediate (Maillard reaction). These Schiff-base intermediates 
undergo Amadori rearrangement to a stable ketoamine derivative 
(fructosamine)[14].
   Sialic acid is a terminal component of the non-reducing end 
of the carbohydrate chains of glycoproteins and glycolipids 
which are essential constituents of many hormones and enzymes 
present in serum and tissues. Serum sialic acid is almost 
completely bound to glycoproteins and lipids. Total sialic acid 
in the serum has received considerable attention as a possible 
marker for cardiovascular disease and mortality[15]. In diabetes 
mellitus, the sialic acid concentrations were found to increase in 
serum and diabetic tissues[5]. In our study, administration of E. 
alsinoides extract decreased the content of sialic acid in the liver 
and kidney of streptozotocin induced diabetic rats (Figure 1). 
4. Discussion 
   In the diabetic state, a deficiency in insulin secretion causes 
derangement of glycoprotein metabolism, which results in 
basal membrane thickening. Excess availability of glucose in 
the hyperglycaemic state accelerates the synthesis of glucose 
basement membrane components i.e. glycoproteins[16]. E. 
alsinoides administration for 45 d to diabetic rats restored the 
levels of glycoproteins in liver and kidney tissues. The decreased 
hyperglycaemic state with increased levels of plasma insulin 
observed in E. alsinoides treated diabetic rats might have been 
responsible for the decrease of glycoproteins levels in liver, 
kidney and pancreas. Our results are in agreement with the 
previous reports of Ramkumar et al[12]and Senthilkumar and 
Subramanian[5].
   From the present study it can be concluded that the treatment 
with ethanolic extract of E. alsinoides restored the levels of 
glycoprotein components in diabetic rats may have been due to 
the normalization of glucose homeostasis.  Thus it can be used in 
the protection of glycation of membrane proteins during diabetes 
mellitus
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